Manufacturing and Selling New Contract-Manufactured Products
First written in FY2016-Q2. 14 of 22 entries say "Restated". Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1AdvancedAnnual report
「We made maximum use of the organic synthesis technologies in which we specialize, strengthened the development of high-value-added products, expanded contract-manufactured products and actively pursued market expansion in growth fields, including electronic materials and products for pharmaceutical applications.」
The Company continues to expand contract-manufactured products as a growth initiative for the final year of ACCEL2026, pursuing market expansion in combination with products for electronic materials and pharmaceutical applications. - 2026-07-03AdvancedEarnings
「For electronic materials-related products, we substantially increased sales of specialty contract-manufactured products by leveraging our strength in synthesis technologies.」
The company specifically reports an increase in sales of specialty contract-manufactured products. - FY2025AdvancedAnnual report
「Sales of specialty contract-synthesized products for the domestic market increased substantially, while overseas sales of general-purpose products also grew.」
The company specifically stated that domestic sales of specialty contract-synthesized products increased substantially. - FY2025-H1RestatedAnnual report
「To achieve the five-year medium-term management plan beginning in 2022, “ACCEL 2026: Driving innovation and accelerating growth,” covering the 121st fiscal year “2022” through the 125th fiscal year “2026,” the Group made growth investments in existing multi-purpose plants during the period to expand production capacity, and expanded contract-manufactured products,」
The company continues its policy of expanding contract-manufactured products under ACCEL2026. - FY2024RestatedAnnual report
「Rapidly and flexibly advancing the use of contract-synthesis technologies developed to date and pursuing market expansion for new, high-value-added products」
The company continues its policy of using contract-synthesis technologies to pursue market expansion for new, high-value-added products. - FY2023RestatedAnnual report
「Making maximum use of the strengths of its existing businesses, the company expanded contract-synthesized products and proposed the development of environmentally compliant rubber chemicals that address market needs in medical rubber application products with strengths in quality and technology」
The company continues to pursue a policy of expanding contract-synthesized products by leveraging its synthesis technologies and other capabilities. - FY2023-Q3AdvancedAnnual report
「In the resin chemicals field, the company secured orders for functional contract-manufactured products by leveraging its synthesis technologies.」
The company reported securing orders for functional contract-manufactured products by leveraging its synthesis technologies. - FY2023-Q2RestatedAnnual report
「Using the synthesis technologies developed to date in which the company specializes, the company focused on expanding contract-synthesized products and manufacturing and selling medical rubber application products, dehydrative condensing agents for medical applications, and products for electronic materials applications with strengths in quality and technology, and actively pursued market expansion in growth fields.」
The company continues to expand contract-synthesized products based on its synthesis technologies and manufacture and sell products for medical and electronic materials applications. - FY2023-Q1RestatedAnnual report
「Using the synthesis technologies developed to date in which the company specializes, the company focused on expanding contract-synthesized products and manufacturing and selling medical rubber application products and dehydrative condensing agents for medical applications with strengths in quality and technology, and actively pursued market expansion in growth fields.」
Based on its core synthesis technologies, the company continues to expand contract-synthesized products and manufacture and sell medical rubber application products and dehydrative condensing agents for medical applications. - FY2022-Q2RestatedAnnual report
「Using the synthesis technologies developed to date in which the company specializes, expanding contract-synthesized products」
The company continues its policy of expanding contract-synthesized products by using its core synthesis technologies. - FY2022-Q1RestatedAnnual report
「Using the company's core synthesis technologies, the company focused on expanding contract-synthesized products and manufacturing and selling medical rubber application products and dehydrative condensing agents for medical applications with strengths in quality and technology, and actively pursued market expansion in growth fields.」
The company continues to expand contract-synthesized products, manufacture and sell medical rubber application products and dehydrative condensing agents for medical applications, and expand markets in growth fields. - FY2021RestatedAnnual report
「Using the company's core synthesis technologies, focusing on expanding contract-synthesized products and manufacturing and selling medical rubber application products and dehydrative condensing agents for medical applications with strengths in quality and technology」
The company continues to focus on expanding contract-synthesized products and manufacturing and selling medical rubber application products and dehydrative condensing agents for medical applications. - FY2021-Q3RaisedAnnual report
「Using the technologies developed to date, focusing on expanding contract-synthesized products and manufacturing and selling medical rubber application products and dehydrative condensing agents for medical applications with strengths in quality and technology」
The wording has become more explicit, shifting from a focus on existing contract-synthesized products to specifying their “expansion.” - FY2021-Q2RestatedAnnual report
「Focusing on the manufacture and sale of contract-synthesized products, medical rubber application products with strengths in quality and technology, and dehydrative condensing agents for medical applications」
The company continues to focus on the manufacture and sale of contract-synthesized products. - FY2021-Q1RestatedAnnual report
「The company actively worked to ensure stable supply amid fluctuations in market demand, while focusing on the manufacture and sale of contract-synthesized products and products with strengths in quality and technology, and pursuing business expansion in growth fields.」
The company continues to focus on the manufacture and sale of contract-synthesized products. - FY2020-Q2RestatedAnnual report
「We focused on manufacturing and selling contract-manufactured products for which demand was increasing, as well as medical and pharmaceutical products with advantages in quality and technology.」
The company continues to focus on the manufacture and sale of contract-synthesized products. - FY2020-Q1RestatedAnnual report
「The company actively worked to ensure stable supply amid fluctuations in demand in rapidly changing domestic and overseas markets, while focusing on the manufacture and sale of contract-synthesized products and products with strengths in quality and technology.」
The company continues to focus on the manufacture and sale of contract-synthesized products. - FY2019RestatedAnnual report
「Actively advance the development and market proposals for new products, as well as contract synthesis」
The policy of actively advancing contract synthesis was also stated for the full year. - FY2018AdvancedAnnual report
「In Other fields, sales exceeded the same period of the previous year as active market development for contract-manufactured and existing products expanded sales of new products and increased sales of existing products through new demand.」
The company reported expanded sales of new products and increased sales of existing products driven by new demand through market development for contract-manufactured and existing products. - FY2016RestatedAnnual report
「In Japan, while focusing on expanding sales of existing products and manufacturing and selling new contract-manufactured products and securing orders」
The company continued to cite its focus on manufacturing and selling new contract-manufactured products and securing orders for the full year. - FY2016-Q3AdvancedAnnual report
「In Japan, while focusing on the manufacturing and sales of new contract-manufactured products and securing orders」
In addition to reiterating its policy of focusing on new contract-manufactured products, the company reported the concrete progress of securing orders. - FY2016-Q2First statedAnnual report
「While focusing on the manufacture and sale of new contract-manufactured products」
The manufacture and sale of new contract-manufactured products is being used as a means of expanding the business.